2024 Annual Meeting | C157 - Challenging Clinical Cases in Pediatric Neurocritical Care: Diagnosis, Management, and Prognostication

Date Wednesday 04/17/24

Time 07:00 AM - 09:00 AM MDT Add To Calendar

Location Colorado Convention Center | 102/104/106

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Matthew Kirschen, MD, PhD, FAAN

Topic(s) Neuro Trauma and Critical Care

Learning Objectives Faculty will define scenarios for when continous EEG is indicated in pediatric patients with acute brain injury, discuss risks and benefits of aggressive treatment of subclincal seizures in children with acute brain injuries, describe the pharmacology of ketamine and its role in seizure management, and explore potential risks and benefits from early use of ketamine to treat status epilepticus in critically ill children.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:05 AM MDT	Introduction	Challenging Clinical Cases in Pediatric Neurocritical Care: Diagnosis, Management, and Prognostication Matthew Kirschen, MD, PhD, FAAN
07:05 AM - 07:15 AM MDT	Speaker	Epidemiology of Subclinical Seizures After Acute Brain Injury Giulia Benedetti, MD
07:15 AM - 07:30 AM MDT	Speaker	Subclinical Seizures: Did We Open Pandora’s Box or Let Out Schrodinger’s Cat? Craig A. Press, MD, PhD
07:30 AM - 07:45 AM MDT	Speaker	Subclinical Seizures: Did We Open Pandora’s Box or Let Out Schrodinger’s Cat? Rodney C. Scott, MD, PhD
07:45 AM - 08:10 AM MDT	Discussion	Discussion Matthew Kirschen, MD, PhD, FAAN
08:10 AM - 08:25 AM MDT	Speaker	Dissociating Seizures: Ketamine's Role in the Treatment of Status Epilepticus? Raquel Farias-Moeller, MD
08:25 AM - 08:40 AM MDT	Speaker	Dissociating Seizures: Ketamine's Role in the Treatment of Status Epilepticus? Matthew Kirschen, MD, PhD, FAAN
08:40 AM - 09:00 AM MDT	Discussion	Discussion Matthew Kirschen, MD, PhD, FAAN

Faculty Disclosures
Matthew Kirschen, MD, PhD, FAAN	The institution of Dr. Kirschen has received research support from NIH.
Craig A. Press, MD, PhD	Dr. Press has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Marinus Pharmaceuticals. Dr. Press has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law Firms. Dr. Press has received research support from Marinus Pharmaceuticals. Dr. Press has received research support from Pediatric Epilepsy Research Foundation. Dr. Press has received research support from NIH.
Giulia Benedetti, MD	The institution of Dr. Benedetti has received research support from Pediatric Epilepsy Research Foundation. The institution of Dr. Benedetti has received research support from NIH.
Raquel Farias-Moeller, MD	Dr. Farias-Moeller has nothing to disclose.
Rodney C. Scott, MD, PhD	Dr. Scott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BTG Pharmaceuticals.